ONCOBIOLOGICS INC - *W EXP 05/18/201 (ONSIZ)

CUSIP: 68235M121

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / *W EXP 05/18/201
Total 13F shares
2,718,056
Share change
+661,179
Total reported value
$3,396,000
Price per share
$1.20
Number of holders
12
Value change
+$931,553
Number of buys
4
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 68235M121?
CUSIP 68235M121 identifies ONSIZ - ONCOBIOLOGICS INC - *W EXP 05/18/201 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOBIOLOGICS INC - *W EXP 05/18/201 (ONSIZ) as of Q3 2016

As of 30 Sep 2016, ONCOBIOLOGICS INC - *W EXP 05/18/201 (ONSIZ) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,718,056 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LLC, venBio Select Advisor LLC, Marshall Wace LLP, PointState Capital LP, ACUTA CAPITAL PARTNERS, LLC, Jefferies Group LLC, MILLENNIUM MANAGEMENT LLC, and Monashee Investment Management LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.